<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-pharmaceuticals-14-00381">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Soto</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>GÃ¡lvez</surname>
    <given-names>N.M.</given-names>
   </name>
   <name>
    <surname>Pacheco</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Bueno</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Kalergis</surname>
    <given-names>A.M.</given-names>
   </name>
  </person-group>
  <article-title>Antibody development for preventing the human respiratory syncytial virus pathology</article-title>
  <source>Mol. Med.</source>
  <year>2020</year>
  <volume>26</volume>
  <fpage>1</fpage>
  <lpage>10</lpage>
  <pub-id pub-id-type="doi">10.1186/s10020-020-00162-6</pub-id>
 </element-citation>
</ref>
